跳至主要内容
临床试验/NCT02657525
NCT02657525Unknown不适用

Acute Exacerbation of Chronic Obstructive Pulmonary Disease Inpatient Registry Study

China-Japan Friendship Hospital0 个研究点目标入组 7,600 人开始时间: 2016年1月最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
7,600
主要终点
In-hospital mortality

研究概览

简要总结

The purpose of this study is to investigate the demographic characteristics, clinical features, diagnoses and treatments of AECOPD hospitalized patients in China, and disease prognosis and its economic burden.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ≥18 years of age; hospitalized patients with main diagnosis as AECOPD.

排除标准

  • Patients diagnosed as active pulmonary tuberculosis, or acute left heart failure; Patients participating in clinical trials or intervention studies of drugs.

结局指标

主要结局

In-hospital mortality

时间窗: 12 months

All-cause and cause-specific mortality will be described.

Readmission

时间窗: 12 months

Readmission rate caused by AECOPD within 1 month after discharged from hospital.

次要结局

  • All-cause and cause-specific mortality(3 years)
  • Recurrence of acute exacerbation of COPD(3 years)
  • Lung function and quality of life assessment(3 years)
  • Healthcare costs(12 months)

研究者

发起方
China-Japan Friendship Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Chen Wang

Prof.Dr.

China-Japan Friendship Hospital

相似试验